Mid-day market update: Dow falls over 100 points, Silicon Laboratories shares spike higher


Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 46,497,710 cases with around 759,930 deaths. India confirmed a total of at least 34,215,650 cases and 455,680 deaths, while Brazil reported over 21,748,980 COVID-19 cases with 606,290 deaths. In total, there were at least 245,403,800 cases of COVID-19 worldwide with more than 4,981,390 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares gained by 0.8% on Wednesday. Meanwhile, top gainers in the sector included Qutoutiao Inc. QTT +1.9% (Get Free Alerts for QTT), up 6% and Stagwell Inc. STGW +5.64% (Get Free Alerts for STGW) up 5%.

In trading on Wednesday, energy shares fell 1.5%.

Top Headline

The Coca-Cola Company KO +1.97% reported better-than-expected results for its third quarter.

Coca-Cola reported quarterly adjusted earnings of $0.65 per share, exceeding analysts’ estimates of $0.58 per share. The company’s sales came in at $10.00 billion, versus expectations of $9.75 billion.

Equities Trading UP

AgriFORCE Growing Systems, Ltd. AGRI +141.67% shares shot up 143% to $5.25. AgriFORCE Growing Systems reported binding LOI to acquire a European
agriculture/horticulture and AgTech consulting firm for $29 million.

Shares of Enphase Energy, Inc. ENPH +27.51% got a boost, shooting 21% to $210.64 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.

Silicon Laboratories Inc. SLAB +17.2% shares were also up, gaining 15% to $178.13 after the company reported better-than-expected Q3 results and issued Q4 adjusted EPS guidance above estimates.

Equities Trading DOWN

Cortexyme, Inc. CRTX -75.07% shares tumbled 74% to $14.96 after the company shared an update. Cortexyme reported Phase 2/3 GAIN trial data for its Alzheimer’s disease trial. The company stated co-primary endpoints were not met for ADAS-Cog11 and ADCS-ADL in the overall population. Subgroups saw a 50% slowing level for infection for ADAS-Cog11.

Shares of Angion Biomedica Corp. ANGN -54.09% were down 54% to $4.0050. After flopping a test in COVID-19 earlier this year, Angion Biomedica’s lead candidate drug has hit a setback again, this time in kidney transplant patients. Angion and partner Vifor Pharma's ANG-3777 failed to beat placebo in terms of improving eGFR, a measure of kidney function, in patients who received a deceased donor kidney transplant and were at high risk of developing delayed graft function.

DBV Technologies S.A. DBVT -25.75% was down, falling 28% to $3.64 after the company reported a loss for the third quarter.

Commodities

In commodity news, oil traded down 1.7% to $83.24, while gold traded down 0.1% to $1,792.90.

Silver traded up 0.3% Wednesday to $24.165 while copper fell 2% to $4.3975.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.42%, the Spanish Ibex Index fell 0.35% and the German DAX 30 declined 0.36%. Meanwhile, the London’s FTSE 100 fell 0.29%, French CAC 40 fell 0.23% and Italy’s FTSE MIB declined 0.71%.

Loans to households in the Eurozone climbed 4.1% year-over-year in September. Industrial producer prices in the France’s domestic market rose 1.7% from a month ago in September, while consumer confidence declined to 99 in October from a revised level of 101 in September.

Import prices in Germany rose 17.7% year-over-year in September, while GfK consumer climate indicator rose to 0.9 heading into November.

Economics

US durable goods orders fell 0.4% for September.

The US goods trade deficit widened to $96.25 billion in September.

US wholesale inventories increased 1.1% to $739.5 billion for September.

US crude oil inventories climbed 4.267 million barrels in the week ending October 22, following a 0.431 million drop in the prior period, the Energy Information Administration said.

The Treasury is set to auction 5-year notes at 1:00 p.m. ET.

Benzinga does not provide investment advice. All rights reserved.

Recommended Content


Recommended Content

Editors’ Picks

AUD/USD hovers around 0.6500 amid light trading, ahead of US GDP

AUD/USD hovers around 0.6500 amid light trading, ahead of US GDP

AUD/USD is trading close to 0.6500 in Asian trading on Thursday, lacking a clear directional impetus amid an Anzac Day holiday in Australia. Meanwhile, traders stay cautious due ti risk-aversion and ahead of the key US Q1 GDP release. 

AUD/USD News

USD/JPY finds its highest bids since 1990, near 155.50

USD/JPY finds its highest bids since 1990, near 155.50

USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, testing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming Japanese intervention risks. Focus shifts to Thursday's US GDP report and the BoJ decision on Friday. 

USD/JPY News

Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data

Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data

Gold price remains confined in a narrow band for the second straight day on Thursday. Reduced Fed rate cut bets and a positive risk tone cap the upside for the commodity. Traders now await key US macro data before positioning for the near-term trajectory.

Gold News

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.

Read more

Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance Premium

Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance

This must be "opposites" week. While Doppelganger Tesla rode horrible misses on Tuesday to a double-digit rally, Meta Platforms produced impressive beats above Wall Street consensus after the close on Wednesday, only to watch the share price collapse by nearly 10%.

Read more

Majors

Cryptocurrencies

Signatures